Weight Loss & Metabolic Health
What Is Tirzepatide?
Last reviewed: May 2026 · Haute MD Editorial Team
Tirzepatide is a once-weekly injectable medication that activates both GIP and GLP-1 receptors, slowing gastric emptying, suppressing appetite, and improving insulin sensitivity. Marketed as Mounjaro for type 2 diabetes and Zepbound for weight loss, it produces average weight reductions of 15–22.5% over 72 weeks in clinical trials — the highest of any FDA-approved weight-loss medication to date.
How tirzepatide works
Tirzepatide is a 'twincretin' — the first medication to activate both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual action slows gastric emptying, suppresses appetite at the hypothalamic level, improves insulin sensitivity, and reduces 'food noise' in the brain. The combined GIP/GLP-1 mechanism appears to produce greater weight loss than GLP-1 alone (semaglutide) in head-to-head comparisons.
Clinical effectiveness and dosing
In the SURMOUNT-1 trial, patients without diabetes lost an average of 15% (5 mg dose), 19.5% (10 mg), and 20.9% (15 mg) of body weight over 72 weeks. Tirzepatide is started at 2.5 mg weekly and titrated up every 4 weeks based on tolerance. Most patients reach effective doses (5–15 mg) within 4–5 months. Type 2 diabetics typically see A1c reductions of 1.7–2.4 points along with weight loss.
Side effects, candidates, and cost
Common side effects mirror other GLP-1s: nausea, vomiting, diarrhea, constipation, and fatigue, particularly during titration. Rare but serious risks include pancreatitis, gallbladder disease, and a contraindication in patients with personal or family history of medullary thyroid cancer or MEN2. FDA-approved for BMI ≥30, or ≥27 with weight-related comorbidities. List price is around $1,000–1,300/month; coverage varies; compounded versions exist but have raised quality concerns. Should be prescribed and monitored by a qualified physician with attention to protein intake and muscle preservation.
Frequently Asked Questions
Is tirzepatide better than semaglutide?
Head-to-head, tirzepatide produces greater average weight loss (~20% vs ~15%). Individual responses vary; some patients tolerate one better than the other.
How long do I take tirzepatide?
Many patients take it long-term, similar to medications for blood pressure or cholesterol. Discontinuation typically leads to significant regain. Decision is individualized with your physician.
Does insurance cover Zepbound?
Coverage is improving but inconsistent. Mounjaro is more often covered for diabetes than Zepbound for weight loss; many patients pay cash or use manufacturer savings programs.
Is compounded tirzepatide safe?
Quality varies. With the FDA shortage resolved, compounded versions face restrictions. Brand-name tirzepatide from a licensed pharmacy is the safest option.
Get Help Now
Speak with a Haute MD Internal Medicine physician
Dr. Alexander Golberg
Internal Medicine · New York, NY
View Profile
Dr. Kern Brar
MD
Internal Medicine · Oceanside, CA
View ProfileAre you a Internal Medicine physician?
Join Haute MD Network and have your profile featured alongside these answers.
Apply for the NetworkRelated Guides
Guide · WEIGHT LOSS & METABOLIC HEALTH
What Is Zepbound?
Zepbound is tirzepatide approved by the FDA for chronic weight management and obstructive sleep apnea. Same molecule as Mounjaro, with average weight loss of 20%+.
Read GuideGuide · WEIGHT LOSS & METABOLIC HEALTH
How Does Mounjaro Work?
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist producing up to 22% body weight loss — more than any previous weight loss medication.
Read GuideGuide · WEIGHT LOSS & METABOLIC HEALTH
What Is a GLP-1 Medication?
GLP-1 medications like Ozempic and Wegovy produce significant weight loss and metabolic improvement by reducing appetite and slowing gastric emptying.
Read Guide